Covered Stent Treatment for Sinus Venosus Atrial Septal Defects: Early Promise and Potential Limitations

Glen Van Arsdell; Doff B. McElhinney

doi:10.1161/circulationaha.124.072394

Covered Stent Treatment for Sinus Venosus Atrial Septal Defects: Early Promise and Potential Limitations

G Glen Van Arsdell (David Geffen School of Medicine at UCLA, Los Angeles, California, United States) D Doff B. McElhinney (Stanford School of Medicine, California (D.B.M.).)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 151, Issue 11

Published March 18, 2025

Pages 757-759

DOI 10.1161/circulationaha.124.072394

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (2)

G

Glen Van Arsdell

David Geffen School of Medicine at UCLA, Los Angeles, California, United States

D

Doff B. McElhinney

Stanford School of Medicine, California (D.B.M.).

Covered Stent Treatment for Sinus Venosus Atrial Septal Defects: Early Promise and Potential Limitations

Article Details

Journal Info

Authors (2)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”